Risk factor | Nosocomial N = 22 n/n(%) | Crude OR (95 % CI) | p value | Adjusted b OR (95 % CI) | p value |
---|---|---|---|---|---|
Age | |||||
< 6 months | 9/160(5.6) | 1 | 1 | ||
≥ 6 months | 13/66(19.7) | 4.11 (1.66–10.18) | 0.002 | 3.35 (1.20–9.36) | 0.02 |
Gender | |||||
Male | 9/117(7.7) | 1 | 1 | ||
Female | 13/109(11.9) | 1.63 (0.67–3.97) | 0.29 | 1.90 (0.69–5.24) | 0.22 |
Weight-for-age z score | |||||
Appropriate | 10/134(7.5) | 1 | 1 | ||
Underweight | 12/92(13) | 1.86 (0.78–4.51) | 0.17 | 1.55 (0.56–4.3) | 0.40 |
Pre-existing conditions other than HIV infection | |||||
Yes | 17/113(15) | 1 | 1 | ||
No | 5/113(4.4) | 0.23 (0.09–0.74) | 0.01 | 0.40 (0.13–1.27) | 0.12 |
HIV status a | |||||
Unexposed uninfected | 15/164(9.2) | 1 | 1 | ||
Exposed uninfected | 4/47(8.5) | 0.93 (0.29–2.93) | 0.89 | 1.26 (0.36–4.40) | 0.72 |
Exposed infected | 1/4(25.0) | 3.31 (0.32–33.84) | 0.31 | 4.31 (0.34–55.44) | 0.26 |
RSV genotype | |||||
N A1 | 14/127(11.0) | 1 | 1 | ||
NA2 | 0/9(0) | NA | NA | ||
ON1 | 5/45(11.1) | 1.01 (0.34–2.98) | 0.34 | 0.84 (0.26–2.73) | 0.77 |
BA4 | 3/45(6.7) | 0.58 (0.16–2.11) | 0.16 | 0.70 (0.18–2.81) | 0.62 |